Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 2. Safety and complications

Autologous hematopoietic stem cell transplantation in the treatment of systemic sclerosis. Part 2. Safety and complications

Autologous hematopoietic stem cell transplantation (auto-HSCT) is presently the only disease-modifying strategy for the treatment of systemic sclerosis (SSs) that has Level A evidence, the effectiveness of which has been proven in three controlled clinical trials: ASSIST, ASTIS, and SCOT. Despite th...

Full description

Saved in:
Bibliographic Details
Main Authors: O. B. Ovsyannikova, L. P. Ananyeva, O. A. Koneva, L. A. Garzanova, O. V. Desinova, R. U. Shayakhmetova, M. N. Starovoitova, A. M. Lila
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2021-02-01
Series:Современная ревматология
Subjects:
systemic sclerosis
autotransplantation
hematopoietic stem cells
complications
transplantation, side effects
Online Access:https://mrj.ima-press.net/mrj/article/view/1102
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://mrj.ima-press.net/mrj/article/view/1102

Similar Items